University of Oxford - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Oxford - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Oxford - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Oxford - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
57 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses under humanities, mathematical, physical and life sciences; medical sciences, and continuity education departments. Its mathematical, physical and life sciences courses comprise doctoral training programs, chemistry, computer science, earth sciences, engineering science, materials, mathematics, physics, plant sciences, statistics and zoology, among others. The university offers various undergraduate courses, graduate courses, lifelong learning and online and distance courses through its colleges.

University of Oxford - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the compa

  
Source:
Document ID
GDPH67724D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
University of Oxford, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
University of Oxford, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
University of Oxford, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
University of Oxford, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201691
University of Oxford, Medical Devices Deals, 2010 to YTD 2016101
University of Oxford, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016114
University of Oxford, Pharmaceuticals &Healthcare, Deal Details1538
  Venture Financing151
    Genomics Raises USD16 Million in Venture Financing152
    Adaptimmune Raises USD104 Million in Series A Venture Financing172
    Oxitec Raises USD10.2 Million in Venture Financing192
    Chronos Therapeutics Raises US$13 Million In Venture Financing212
  Partnerships231
    Idogen Enters into Agreement with University of Oxford231
    Sound Pharma to Partner with University of Oxford241
    Summit Therapeutics Enters into Agreement with University of Oxford251
    Genomics Enters into Agreement with Oxford University and Oxford University Hospitals NHS261
    Wave Life Sciences Enters into Research Agreement with University of Oxford271
    Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement281
    Emergent BioSolutions Signs Agreement with Oxford University, GlaxoSmithKline and NIAID for the Production of an MVA Ebola Zaire Vaccine Candidate292
    Chan Soon-Shiong Institute Forms Joint Venture with University of Oxford311
    Bayer HealthCare Enters Co-Development Agreement with University of Oxford321
    MRC Technology Enters Into Co-Development Agreement With Oxford University331
    Creeyan Labs Enters Into Co-Development Agreement With Oxford University341
    iQur Enters Into Co-Development Agreement With Edward Jenner Institute For Malaria Vaccine351
    Emerald Biostructures Enters Into Co-Marketing Agreement With University of Oxford For PiMS Technology361
    Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford371
    Novo Nordisk Enters Into Co-Development Agreement With Oxford University381
    UCB Enters Into Co-Development Agreement With Oxford University391
    ValiRx Enters Into Co-Development Agreement With Oxford University401
    Cancer Research UK Enters Into Joint Venture Agreement With University Of Oxford And Oxford Radcliffe411
    Sanofi-Aventis And Oxford University Enter Into Research Agreement With INDOX422
    Kennedy Institute of Rheumatology Trust Enters Into Collaboration Agreement With University of Oxford441
    Isconova Enters Into Agreement With Jenner Institute To Develop Vaccines451
    Oxford Nanopore Technologies Enters Into Collaboration With University Of Oxford461
  Licensing Agreements471
    Vaccitech Enters into Licensing Agreement with University of Oxford471
    Rogne Bioscience Enters Into Licensing Agreement with Isis Innovation481
    ExpreS2ion Biotech Enters Into Licensing Agreement With University of Oxford For ExpreS2491
    Oxford Nutrascience Enters Into Licensing Agreement With Isis Innovation501
    Imaxio Enters Into Licensing Agreement With Isis Innovation511
  Equity Offering521
    Perspectum Diagnostics Raises USD5 Million in Financing521
University of Oxford - Key Competitors531
Key Employees541
Locations And Subsidiaries552
  Head Office551
  Other Locations &Subsidiaries552
Appendix571
  Methodology571
  About GlobalData571
  Contact Us571
  Disclaimer571

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Oxford - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Oxford-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17178>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Oxford - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Oxford-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17178>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research